ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Transmembrane Transporters >CFTR inhibitors >Ataluren (PTC124)

Ataluren (PTC124)

Ataluren (PTC124) Structure
CAS No.
775304-57-9
Chemical Name:
Ataluren (PTC124)
Synonyms
Ataluren;Ptc124;CS-749;Ptc-124;Ptc 124;Atarulon;Ataluren [usan];Ataluren, >=98%;PTC-124,ataluren;Ataluren (PTC124)
CBNumber:
CB02128667
Molecular Formula:
C15H9FN2O3
Molecular Weight:
284.24
MOL File:
775304-57-9.mol
MSDS File:
SDS
Modify Date:
2024/4/24 17:21:39

Ataluren (PTC124) Properties

Melting point 241 - 242°C
Boiling point 503.7±60.0 °C(Predicted)
Density 1.379
storage temp. Refrigerator
solubility DMSO (Slightly)
form White to off-white solid.
pka 3.58±0.10(Predicted)
color White to Off-White
InChI InChI=1S/C15H9FN2O3/c16-12-7-2-1-6-11(12)14-17-13(18-21-14)9-4-3-5-10(8-9)15(19)20/h1-8H,(H,19,20)
InChIKey OOUGLTULBSNHNF-UHFFFAOYSA-N
SMILES C(O)(=O)C1=CC=CC(C2N=C(C3=CC=CC=C3F)ON=2)=C1
CAS DataBase Reference 775304-57-9

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Warning
Hazard statements  H336-H373
Precautionary statements  P260-P271-P304+P340+P312-P314-P403+P233-P405
HS Code  2933998090

Ataluren (PTC124) price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) 5.30918 PTC-124 - CAS 775304-57-9 - Calbiochem 775304-57-9 25MG ₹18830 2022-06-14 Buy
Product number Packaging Price Buy
5.30918 25MG ₹18830 Buy

Ataluren (PTC124) Chemical Properties,Uses,Production

Description

Ataluren is a drug marketed under the trade name Translarna® which was developed by PTC Therapeutics and approved by the European Union in May 2014 for the treatment of Duchenne’s muscular dystrophy (DMD) and potentially other genetic disorders. Ataluren renders ribosomes less sensitive to premature stop or ‘read-through’ codons, which are thought to be beneficial in diseases such as DMD and cystic fibrosis.

Uses

Nonsense mutations create a premature termination of mRNA translation and have been implicated in various genetic disorders, including muscular dystrophy and cystic fibrosis. PTC-124 is a nonaminoglycoside that has been reported to selectively induce ribosomes to read through premature nonsense stop signals on mRNA, thus allowing the production of full-length, functional proteins. In a mouse model of cystic fibrosis caused by nonsense mutations, PTC-124 treatment (60 mg/kg s.c. injection or 0.3-0.9 mg/ml orally) has been shown to restore cystic fibrosis transmembrane conductance regulator (CFTR) protein expression and function. The target activity of PTC-124 was initially evaluated by firefly luciferase reporter cell-based nonsense codon assay (IC50 = 7 nM); however, subsequent assessments using a Renilla reniformis luciferase reporter have failed to produce nonsense codon suppression activity. Thus, while PTC-124 is in clinical testing in patients with nonsense mutations within the CFTR or dystrophin genes, controversy surrounds its exact mechanism of action.[Cayman Chemical]

Synthesis

The sequence to construct ataluren, which was described by the authors at PTC Therapeutics, commenced with commercially available methyl 3-cyanobenzoate (38). This ester was exposed to hydroxylamine in aqueous tert-butanol and warmed gently until the reaction was deemed complete. Then this mixture was treated with 2-fluorobenzoyl chloride dropwise and subsequently triethylamine dropwise. To minimize exotherm and undesired side products, careful control of the addition of reagents was achieved through slow dropwise addition of these liquid reagents. Upon complete consumption of starting materials and formation of amidooxime 39, the aqueous reaction mixture was then heated to 85 ?? to facilitate 1,2,4-oxadiazole formation, resulting in the tricyclic ester 40 in excellent yield across the three steps. Finally, saponification of ester 40 through the use of sodium hydroxide followed by acidic quench gave ataluren (V) in 96% over the two-step sequence.

Synthesis_775304-57-9

Global( 219)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Shanghai Famo Biotech Co Ltd +8618550473860 China 513 58 Inquiry
shandong perfect biotechnology co.ltd +86-53169958659; +8618596095638 China 294 58 Inquiry
Henan Bao Enluo International TradeCo.,LTD +86-17331933971 +86-17331933971 China 2503 58 Inquiry
Hangzhou ICH Biofarm Co., Ltd +86-0571-28186870; +undefined8613073685410 China 985 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29901 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry

Ataluren (PTC124) Spectrum

Ptc-124 PTC-124,ataluren Ataluren (PTC124) Ataluren PTC 124 Ataluren Ataluren, >=98% PTC124, 775304-57-9 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid Ataluren [usan] Benzoic acid, 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)- Ptc 124 Atarulon CS-749 ATALUREN;PTC-124;PTC 124 Ataluren (PTC124) USP/EP/BP Ptc124 Ataluren 4H-1-Benzopyran-4-one,6-bromo-2,3-dihydro-2,7-dimethyl- Estr-4-en-3-one,17-hydroxy-,(21β)- 775304-57-9 C15H9FN2O3 Inhibitors Ribosome binding agent API